Twitter | Search | |
This is the legacy version of twitter.com. We will be shutting it down on 15 December 2020. Please switch to a supported browser or device. You can see a list of supported browsers in our Help Center.
Search Refresh
Aadil Ahmed Oct 29
Btw for funsies this is the town in Germany after which CD30 was named..Any guesses
Reply Retweet Like
Joseph Susa, DO Oct 29
Replying to @DermpathJC @NRiddleMD
Found this in J Cutan Pathol 2008: 35: 1100–1107 Cerroni et al. Large CD30-positive cells in benign,atypical lymphoid infiltrates of the skin
Reply Retweet Like
Mitul B. Modi, MD Dec 5
Amazing topic, here to see what expert Dermatopathologists come across and how do they manage!
Reply Retweet Like
Aadil Ahmed Oct 29
While its customary to quantify CD30 expression in LPDs, there is a lack of correlation between clinical outcome and CD30 expression (at least by IHC) that was evident by phase 2 trial of Brentuximab itself. Similar case in non-cutaneous LPDs
Reply Retweet Like
Laleh Montaser Apr 30
Hi, I am here too! From Boston! Everything is still virtual here!
Reply Retweet Like
Aadil Ahmed Oct 29
Finishing and joining 😅from Little Rock, AR, No COI
Reply Retweet Like
Mariantonieta Tirado Sep 24
The problem also is that many biopsies for PLC are shaves
Reply Retweet Like
Etan Marks, DO Jan 23
What about asteatotic dermatitis and scleredema. Recently had both of those, very difficult without clinical info
Reply Retweet Like
Jisun Cha MD FAAD Oct 29
CD30 also frequently expressed in cutaneous mastocytosis (96.5%) according to this article.
Reply Retweet Like
Joseph Susa, DO Oct 29
Awesome trivia! I had no idea!! Litterally searched a list of german cities begining with Ki!
Reply Retweet Like
Riddhish Sheth, MD Oct 17
Thank you very much for this great opportunity. I really enjoyed working on this. I hope for the opportunity to continue participating in the
Reply Retweet Like
Stanton Miller Sep 24
I thought the utility of IHCs in PL was quite fascinating! Hadn't considered the occasional similarities to LyP. Beware the CD30!
Reply Retweet Like
Pathosomes Sep 24
Replying to @sunpungi
No, do not recall seeing it, but will be on the look out now.
Reply Retweet Like
Frank Ingram, MD Apr 30
Whenever I see a carcinosarcoma (usually GYN or breast in my practice) I’m reminded that the epithelial/mesenchymal distinction is a construct of the human mind. The tumors that cross the dividing line are only doing so because we drew a line.
Reply Retweet Like
Jisun Cha MD FAAD Oct 29
I think this article was a good one especially for now because CD30 is a hot issue after the antibody became available and does a wonderful job for some retractable lymphoma that doesn’t respond to anything else.
Reply Retweet Like
Abdullah Alswied Dec 5
Here to learn new things 🤓🤓 Abdullah from the University of Arizona. No COI
Reply Retweet Like
Stanton Miller Sep 24
Replying to @FungMaxwell
As soon as I googled it and compared it to the histo pics, it immediately made sense to me!
Reply Retweet Like
Joseph Susa, DO Oct 29
It has been reported. Have never seen it personally, but then I haven't often looked :)
Reply Retweet Like
Stanton Miller Sep 24
Excited to talk/read about Pityriasis Lichenoides at tonights ! Such a fascinating disease (group of diseases?)both clinically/pathologically
Reply Retweet Like
Celestine Trinidad, MD Oct 29
One of the interesting points in the paper for me was the differences in prognosis of CD30 expression: in C-MF this had an unfavorable prognosis, while in T-MF this was associated with a better outcome.
Reply Retweet Like